Featured perspective
Common Femoral Artery Disease: Algorithms and Treatment Decisions
A practical approach to selecting open or endovascular treatment for CFA atherosclerotic disease based on patient risk, lesion anatomy, and expected durability.
Route 92 Medical, Inc. announced FDA 510(k) clearance for the FreeClimb 46 catheter with Tenzing 4. The two components are engineered as an integrated system to provide neurovascular access.
Rapid Medical announced that its Tigertriever 17 Ultra has received CE Mark approval, expanding its portfolio of adjustable clot retrievers for ischemic stroke.
Anaconda Biomed announced the closing of a $56 million financing round with participation from new and existing investors.
Italy-based Dialybrid announced commencement of the first-in-human trial of its arteriovenous graft for vascular access in hemodialysis.
The new gloves are designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided and image-dependent procedures.
Piraeus Medical announced the United States launch and first clinical cases of the company’s 6-F 70 NeuGlide catheter.
Device intelligence
This searchable guide offers a comprehensive listing of available vascular interventional devices in the United States.
Device intelligence
This searchable guide offers a comprehensive listing of available vascular interventional devices in Europe.
By Jeffrey G. Carr, MD
The role of access, early diagnosis, multidisciplinary care, and innovation in improving limb outcomes.
With Mohsen Nouri, MD; Robert M. Starke, MD; and colleagues
By Manolo Rubio, MD
What’s new, what changed, and what the newest trials add.
By Rishi Razdan, MD
Featured center